(Press-News.org) Reston, VA (October 10, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
Many Patients Benefit from Continuing PSMA Therapy Despite Early PSA Rise
A new study from the ProsTIC registry examined men with advanced prostate cancer receiving 177Lu-PSMA-617 therapy who showed no early PSA decline after the first treatment cycle. Researchers found that nearly half of the men later achieved significant PSA reductions or pain relief, highlighting the importance of continuing therapy beyond early PSA results.
New PET/CT Scan May Improve Surgery Decisions in Pancreatic Cancer
In patients with pancreatic ductal adenocarcinoma, 68Ga-FAPI PET/CT uncovered hidden metastases missed by standard CT in nearly one-third of cases, sparing them unnecessary surgery. The scan’s uptake also correlated with tumor aggressiveness, suggesting this advanced imaging could better guide treatment planning and identify patients most likely to benefit from surgery.
New Procedure Guideline Highlights Molecular Imaging Breakthroughs for Kidney Tumors
A new procedure guideline outlines how molecular imaging can better distinguish aggressive kidney cancers from benign lesions. By combining CAIX-targeted tracers such as 89Zr-girentuximab with mitochondrial agents like 99mTc-sestamibi, clinicians can improve diagnosis and treatment decisions. The guideline also points to AI-driven imaging advances for future kidney cancer care.
Advanced PSMA PET/CT Scan Changes Treatment Plans for High-Risk Prostate Cancer
In a study of 160 men with newly diagnosed high-risk prostate cancer, 18F-PSMA PET/CT imaging revealed previously unseen metastases in one-quarter of patients compared with standard bone scans. The improved detection, especially of lymph node spread, led to major changes in treatment plans for more than 10 percent of participants.
Visit the JNM website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed or follow us on LinkedIn.
###
Please visit the SNMMI Media Center for more information about molecular imaging and precision imaging. To schedule an interview with the researchers, please contact Rebecca Maxey at (703) 652-6772 or rmaxey@snmmi.org.
About JNM and the Society of Nuclear Medicine and Molecular Imaging
The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed 15 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www.snmmi.org.
END
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025
2025-10-10
ELSE PRESS RELEASES FROM THIS DATE:
Destined to melt
2025-10-10
Glaciers are fighting back against climate change by cooling the air that touches their surfaces. But for how long? The Pellicciotti group at the Institute of Science and Technology Austria (ISTA) has compiled and re-analyzed an unprecedented dataset of on-glacier observations worldwide. Their findings, published today in Nature Climate Change, demonstrate that glaciers will likely reach the peak of their self-cooling power by the next decade before their near-surface temperatures spike up and melting accelerates.
Thomas Shaw keeps a vivid memory of this special summer day in August 2022. The postdoctoral researcher in Francesca Pellicciotti’s group at the Institute of Science ...
Attitudes, not income, drive energy savings at home
2025-10-10
Some people flip off the lights the moment they leave a room, while others rarely think twice about saving energy. According to the most comprehensive analysis of people’s sentiments toward household energy savings to date, publishing October 10 in the Cell Press journal Cell Reports Sustainability, people’s attitudes and moral sentiments about their energy usage—rather than income or knowledge of how to conserve power—determine whether they take action at home.
Domestic energy usage accounts for about a fifth of all energy consumption in the United States and European Union. Understanding what matters ...
The playbook for perfect polaritons
2025-10-10
Light is fast, but travels in long wavelengths and interacts weakly with itself. The particles that make up matter are tiny and interact strongly with each other, but move slowly. Together, the two can combine into a hybrid quasiparticle called a polariton that is part light, part matter. In a new paper published today in Chem, a team of Columbia chemists has identified how to combine matter and light to get the best of both worlds: polaritons with strong interactions and fast, wavelike flow. These distinctive behaviors can be used to power optical computers and other light-based quantum ...
‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell
2025-10-10
Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the disease.
The discovery, reported today in Neuron, is a significant step towards understanding the complex mechanisms that drive the disease and provides a promising new avenue for research into more effective therapies for this debilitating condition.
MS is a chronic disease in which the immune system mistakenly attacks ...
Solar-powered method lights the way to a ‘de-fossilized’ chemical industry
2025-10-10
Researchers have demonstrated a new and sustainable way to make the chemicals that are the basis of thousands of products – from plastics to cosmetics – we use every day.
Hundreds of thousands of chemicals are manufactured by the chemical industry, which transforms raw materials – usually fossil fuels – into useful end products. Due to its size and its use of fossil fuel feedstocks, the chemical industry is responsible for roughly 6% of global carbon emissions.
But researchers, led by the University of Cambridge, are developing new methods ...
Screen time linked to lower academic achievement among Ontario elementary students
2025-10-10
Higher levels of screen time in early childhood are associated with lower scores in reading and mathematics on Ontario’s standardised tests, with each additional hour of daily screen time associated with a 10 per cent drop in the likelihood of achieving higher academic levels. Published in JAMA Network Open, the findings are part of a new study from TARGet Kids!, a collaborative research network co-led by Dr. Catherine Birken at The Hospital for Sick Children (SickKids) and Dr. Jonathon Maguire at Unity Health Toronto’s St. Michael’s Hospital.
The study followed more than 3,000 children across Ontario from 2008 to 2023. Researchers ...
One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study
2025-10-10
About The Study: In this cohort study, early extracranial surgery was associated with adverse function, cognition, and disability after traumatic brain injury (TBI) rated as moderate-severe or with radiographic abnormalities on computed tomography (CT) scan regardless of Glasgow Coma Scale at index admission but not after orthopedic trauma or CT− TBI. Further studies may help determine whether surgical timing or other interventions can improve the observed long-term deficits.
Corresponding ...
Enduring outcomes of COVID-19 work absences on the US labor market
2025-10-10
About The Study: In this cohort study of employed workers in the U.S., the new year-round baseline for work absences appeared to be on par with the levels formerly confined to pre-pandemic influenza season conditions. Policymakers should consider the consequences for workers, including the value of policies and actions that mitigate the spread of COVID-19 in the workplace. This study additionally highlights the potential for using nationally representative labor market data to monitor the impacts of ...
Affirmative action repeal and racial and ethnic diversity in us medical school admissions
2025-10-10
About The Study: The findings of this study suggest that elimination of race-conscious admissions coincided with declines in medical school diversity, threatening progress toward health care equity. Medical schools must explore alternative admissions strategies, such as holistic review processes that account for structural barriers. Without such efforts, reduced diversity in medical education may worsen existing health disparities.
Corresponding Author: To contact the corresponding author, Natalie Florescu, MD, MPH, email natalie.florescu@uvmhealth.org.
To access the embargoed study: Visit our For The Media website at this ...
Cancer progression illuminated by new multi-omics tool
2025-10-10
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells. The technology, which can now use diverse types of pathology samples and quickly process large numbers of cells, has enabled the investigators to glean new insights into how cancers evolve toward greater aggressiveness and therapy resistance.
Described in a paper published Oct. 10 in Cell Genomics, the new tool, GoT-Multi, is a next-generation advance ...